is proud to announce that the Dexcom G7 Continuous Glucose Monitoring (CGM) System has now been added to the Alberta Drug Benefit List. In addition, the Alberta government has expanded the ...

At Dexcom’s conference presentation on Monday, Sayer shared that the company had won CGM coverage from two of the three largest pharmacy benefit managers, giving it access to 5 million more people ...

Managing blood sugar levels is a constant balancing act, particularly for individuals with diabetes. But, life doesn’t stand still. Times of change – be it shifts in routine, increased stress, or even ...

DexCom, Inc. DXCM reported strong preliminary results for the fourth quarter and full-year 2024. In response, the company’s stock jumped 2.7% on Jan. 13. The company is scheduled to release its ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM) today reported preliminary, unaudited results for the fourth quarter ended December 31, 2024 with total revenue of at least $1.113 billion, an ...